Book Building - SME
- cr
NA
-
-
BSE - SME
-
-
-
Initial public offer of upto 30,00,000 equity shares of face value of Rs. 10/- each (equity shares) of the company at an issue price of Rs. [*] per equity share (including a share premium of Rs. [*] per equity share) for cash, aggregating up to Rs. [*] crores (public issue) out of which [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The public issue less market maker reservation portion i.e. issue of [*] equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores is hereinafter referred to as the net issue. The public issue and net issue will constitute [*]% and [*]% respectively of the post- issue paid-up equity share capital of the company. The price band and the minimum bid lot will be decided by the company.
Prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company. General Corporate Purpose.
Goldline Pharmaceutical Ltd, Office No S6-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - info@goldlinepharma.in
Website - www.goldlinepharma.in